No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
HUGE FSD Pharma
- 0.3400
- +0.0005+0.15%
Close May 22 16:00 ET
- 0.3334
- -0.0066-1.94%
Post 19:57 ET
14.31MMarket Cap-1360P/E (TTM)
0.3508High0.3200Low94.50KVolume0.3508Open0.3395Pre Close32.29KTurnover0.26%Turnover RatioLossP/E (Static)42.10MShares1.679952wk High1.19P/B12.46MFloat Cap0.306652wk Low--Dividend TTM36.64MShs Float14.0000Historical High--Div YieldTTM9.07%Amplitude0.3066Historical Low0.3410Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Shares of Cannabis Stocks Are Trading Higher After Biden Said the Justice Department Is Taking the Next Steps to Reclassify Marijuana From Schedule I to Schedule III
Express News | President Biden Posts On X "Too Many Lives Have Been Upended Because Of Our Failed Approach To Marijuana. So Today, The @TheJusticeDept Is Taking The Next Step To Reclassify Marijuana From A Schedule I To A Schedule Iii Drug Under Federal Law."
FSD Pharma Unveils Unbuzzd's Fresh New Look
FSD Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Express News | 'DEA Appears To Question Marijuana's Medical Value Despite Rescheduling Recommendation' - Marijuana Moment
FSD Pharma Advances MS Treatment Trials
Comments
$FSD Pharma(HUGE.US$
NEWS
FSD Pharma Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302 (Lucid-MS) for Ethics Committee Review in Australia
NEWS
FSD Pharma Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302 (Lucid-MS) for Ethics Committee Review in Australia
1
$FSD Pharma(HUGE.US$
NEWS
FSD Pharma Signs Agreement with Applied Science and Performance Institute (ASPI) to Conduct a Clinical Trial in the United States to Assess the Safety and Efficacy of unbuzzd(TM) in an Induced State of Alcohol Intoxication
NEWS
FSD Pharma Signs Agreement with Applied Science and Performance Institute (ASPI) to Conduct a Clinical Trial in the United States to Assess the Safety and Efficacy of unbuzzd(TM) in an Induced State of Alcohol Intoxication
$FSD Pharma(HUGE.US$ This sure was a disappointment! But its green! And thats sure better than red by any amount ![]()
5
3
$FSD Pharma(HUGE.US$ FSD Pharma Provides Update From Celly Nu's Partnership With Six+One For Beverage Product Unbuzzd
Benzinga· 8 mins ago
On April 25, 2024, Celly Nu announced a strategic partnership with Six+One, a purpose-driven branding, advertising, and production agency based in New York City.
FSD Pharma has also licensed unbuzzd, a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of quickly relieving indiv...
Benzinga· 8 mins ago
On April 25, 2024, Celly Nu announced a strategic partnership with Six+One, a purpose-driven branding, advertising, and production agency based in New York City.
FSD Pharma has also licensed unbuzzd, a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of quickly relieving indiv...
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg